{"id":112092,"date":"2008-05-28T01:05:25","date_gmt":"2008-05-28T05:05:25","guid":{"rendered":"https:\/\/www.send2press.com\/wire\/cynacon-ocusoftr-announces-ocusoftr-lid-scrubtm-plus-now-available-in-cvs-pharmacies\/"},"modified":"2008-05-28T01:05:25","modified_gmt":"2008-05-28T05:05:25","slug":"cynacon-ocusoftr-announces-ocusoftr-lid-scrubtm-plus-now-available-in-cvs-pharmacies","status":"publish","type":"post","link":"https:\/\/www.send2press.com\/wire\/cynacon-ocusoftr-announces-ocusoftr-lid-scrubtm-plus-now-available-in-cvs-pharmacies\/","title":{"rendered":"CYNACON \/ OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies"},"content":{"rendered":"

NEWS SOURCE: OCuSOFT Inc.<\/strong><\/p>\n

RICHMOND, Texas, May 28 (SEND2PRESS NEWSWIRE) — CYNACON \/ OCuSOFT(R) (OCuSOFT(R), Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to announce that as a convenience to all patients, OCuSOFT(R) Lid Scrub(TM) Plus is now available in CVS pharmacies, nationwide.<\/p>\n

\"Caption:OCuSOFT(R), Inc., recognized as the market leader, recently introduced OCuSOFT(R) Lid Scrub(TM) PLUS for moderate to severe eyelid conditions where bacterial involvement is suspected. <\/p>\n

OCuSOFT(R) Lid Scrub(TM) PLUS is strongly recommended by physicians as a pre-surgical prep or as an adjunct therapy for blepharitis and dry eye conditions.<\/p>\n

In an independent laboratory study, the anti-bacterial effectiveness of OCuSOFT(R) Lid Scrub(TM) Plus demonstrated a 99 percent kill rate for bacteria that included, but was not limited to: S. epidermidis, E.coli, P. aeriginosa, M. catarrhalis, S. marcescens as well as methicillin-resistant S. aureus (MRSA). <\/p>\n

OCuSOFT(R) Lid Scrub(TM) PLUS has been formulated with a moisturizing agent that allows the patient to leave it on. This “Leave on Formula” ensures prolonged contact and maximizes the bacterial time kill rate without rinsing. <\/p>\n

“Even though patients can now purchase the product at CVS, as a convenience, doctors may still make OCuSOFT(R) Lid Scrub(TM) PLUS available to patients in their office,” Troy Smith, Vice President of Sales for OCuSOFT(R) Inc, says. “Special discounts ensure that patients can purchase OCuSOFT(R) Lid Scrub(TM) PLUS from their doctor’s office at prices comparable to that of retail drug stores.” <\/p>\n

OCuSOFT(R) Lid Scrub(TM) PLUS is packaged in convenient pre-moistened pads and is also available in an instant foam pump dispenser. Accordingly, this formula soothes, relieves irritation, and removes contaminants from the eyelids.<\/p>\n

OCuSOFT(R), Inc. is dedicated to addressing clinical needs with novel technological solutions that optimize the delivery and performance of ophthalmic pharmaceutical products, which in turn improve patient care and compliance. <\/p>\n

For a free sample of OCuSOFT(R) Lid Scrub(TM) PLUS, click: www.ocusoft.com\/sample1.html. <\/p>\n

For more information about the company and their products, visit: www.ocusoft.com<\/a>.<\/p>\n

News issued by: OCuSOFT, Inc.<\/p>\n

\"OCuSOFT,<\/p>\n

Original Image: https:\/\/www.send2press.com\/wire\/images\/08-0528-Ocusoft_72dpi.jpg<\/a><\/small><\/p>\n

# # # <\/p>\n

Original Story ID: (4008) :: 2008-05-0528-001<\/small><\/p>\n

Original Keywords: OCuSOFT Lid Scrub PLUS, CYNACON, Troy Smith, ophthalmic pharmaceutical products, CVS pharmacies, moderate to severe eyelid conditions where bacterial involvement is suspected, removes contaminants from the eyelids OCuSOFT, Inc. <\/small><\/p>\n

NEWS SOURCE: OCuSOFT Inc.<\/strong> | Published: 2008-05-28 01:05:25<\/p>\n","protected":false},"excerpt":{"rendered":"

RICHMOND, Texas (SEND2PRESS NEWSWIRE) — CYNACON \/ OCuSOFT(R) (OCuSOFT(R), Inc.), a company specializing in ophthalmic research, development and supply to ophthalmologists and optometrists, is pleased to announce that as a convenience to all patients, OCuSOFT(R) Lid Scrub(TM) Plus is now available in CVS pharmacies, nationwide.<\/p>\n","protected":false},"author":9780,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"singles-wide.php","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[19937],"tags":[],"class_list":["post-112092","post","type-post","status-publish","format-standard","hentry","category-press-releases-archive","has-post-title","has-post-date","no-post-category","no-post-tag","no-post-comment","has-post-author"],"acf":[],"views":490,"_links":{"self":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/112092","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/users\/9780"}],"replies":[{"embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/comments?post=112092"}],"version-history":[{"count":0,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/posts\/112092\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/media?parent=112092"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/categories?post=112092"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.send2press.com\/wire\/wp-json\/wp\/v2\/tags?post=112092"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}